116 related articles for article (PubMed ID: 24126225)
21. Cutaneous nerve terminal degeneration in painful mononeuropathy.
Lin YW; Tseng TJ; Lin WM; Hsieh ST
Exp Neurol; 2001 Aug; 170(2):290-6. PubMed ID: 11476595
[TBL] [Abstract][Full Text] [Related]
22. Antinociceptive property of Emblica officinalis Gaertn (Amla) in high fat diet-fed/low dose streptozotocin induced diabetic neuropathy in rats.
Kumar NP; Annamalai AR; Thakur RS
Indian J Exp Biol; 2009 Sep; 47(9):737-42. PubMed ID: 19957886
[TBL] [Abstract][Full Text] [Related]
23. Generalized depletion of free nerve endings and decrease of cutaneous nervous innervation in streptozotocin-induced painful and painless diabetic rats.
Chu CC; Wang SD; Chiang JS; Ho ST
J Chin Med Assoc; 2012 Jul; 75(7):314-21. PubMed ID: 22824045
[TBL] [Abstract][Full Text] [Related]
24. Regional differences in epidermal thickness and behavioral response following partial denervation of the rat paw.
Kojundzic SL; Dujmovic I; Grkovic I; Sapunar D
Int J Neurosci; 2008 Dec; 118(12):1748-62. PubMed ID: 18937117
[TBL] [Abstract][Full Text] [Related]
25. Tanshinone IIA improves impaired nerve functions in experimental diabetic rats.
Liu Y; Wang L; Li X; Lv C; Feng D; Luo Z
Biochem Biophys Res Commun; 2010 Aug; 399(1):49-54. PubMed ID: 20637731
[TBL] [Abstract][Full Text] [Related]
26. Early changes in insulin receptor signaling and pain sensation in streptozotocin-induced diabetic neuropathy in rats.
Sugimoto K; Rashid IB; Shoji M; Suda T; Yasujima M
J Pain; 2008 Mar; 9(3):237-45. PubMed ID: 18331706
[TBL] [Abstract][Full Text] [Related]
27. [Pathogenesis of peripheral neuropathy in streptozotocin-induced diabetes in rats].
Cai F
Zhonghua Yi Xue Za Zhi; 1989 Feb; 69(2):86-9, 8. PubMed ID: 2527588
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of a long-acting C-peptide analogue against peripheral neuropathy in streptozotocin-diabetic mice.
Jolivalt CG; Rodriguez M; Wahren J; Calcutt NA
Diabetes Obes Metab; 2015 Aug; 17(8):781-8. PubMed ID: 25904006
[TBL] [Abstract][Full Text] [Related]
29. [Effect of the duration of high-fat diet and the dosage of streptozotocin on establishing experimental animal model of type 2 diabetes mellitus].
Wang B; Li Y; Liu X; Liu S; Sun C
Wei Sheng Yan Jiu; 2011 Jan; 40(1):99-102, 106. PubMed ID: 21434325
[TBL] [Abstract][Full Text] [Related]
30. Mechanical hyperalgesia correlates with insulin deficiency in normoglycemic streptozotocin-treated rats.
Romanovsky D; Cruz NF; Dienel GA; Dobretsov M
Neurobiol Dis; 2006 Nov; 24(2):384-94. PubMed ID: 16935517
[TBL] [Abstract][Full Text] [Related]
31. Specific antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy.
Bordet T; Buisson B; Michaud M; Abitbol JL; Marchand F; Grist J; Andriambeloson E; Malcangio M; Pruss RM
J Pharmacol Exp Ther; 2008 Aug; 326(2):623-32. PubMed ID: 18492948
[TBL] [Abstract][Full Text] [Related]
32. Effect of aminoguanidine treatment on diabetes-induced changes in the myenteric plexus of rat ileum.
Shotton HR; Adams A; Lincoln J
Auton Neurosci; 2007 Mar; 132(1-2):16-26. PubMed ID: 16987713
[TBL] [Abstract][Full Text] [Related]
33. Insulin Treatment Attenuates Small Nerve Fiber Damage in Rat Model of Type 2 Diabetes.
Andreasen LJ; Kirk RK; Fledelius C; Yorek MA; Lykkesfeldt J; Akerstrom T
J Diabetes Res; 2020; 2020():9626398. PubMed ID: 32832565
[TBL] [Abstract][Full Text] [Related]
34. The expression of calcium/calmodulin-dependent protein kinase II in the dorsal horns of rats with type 1 and type 2 diabetes.
Boric M; Jelicic Kadic A; Puljak L
Neurosci Lett; 2014 Sep; 579():151-6. PubMed ID: 25067828
[TBL] [Abstract][Full Text] [Related]
35. The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity.
Drel VR; Mashtalir N; Ilnytska O; Shin J; Li F; Lyzogubov VV; Obrosova IG
Diabetes; 2006 Dec; 55(12):3335-43. PubMed ID: 17130477
[TBL] [Abstract][Full Text] [Related]
36. An early diagnostic tool for diabetic peripheral neuropathy in rats.
Kambiz S; van Neck JW; Cosgun SG; van Velzen MH; Janssen JA; Avazverdi N; Hovius SE; Walbeehm ET
PLoS One; 2015; 10(5):e0126892. PubMed ID: 25984949
[TBL] [Abstract][Full Text] [Related]
37. Skin denervation, neuropathology, and neuropathic pain in a laser-induced focal neuropathy.
Chiang HY; Chen CT; Chien HF; Hsieh ST
Neurobiol Dis; 2005 Feb; 18(1):40-53. PubMed ID: 15649695
[TBL] [Abstract][Full Text] [Related]
38. [Effect of substance P combined with epidermal stem cells on wound healing and nerve regeneration in rats with diabetes mellitus].
Zhu FB; Liu DW; Zhang HY; Xu JC; Peng Y; Zhong QL; Li YT
Zhonghua Shao Shang Za Zhi; 2012 Feb; 28(1):25-31. PubMed ID: 22490536
[TBL] [Abstract][Full Text] [Related]
39. Structural impairments in optic nerve of diabetic rats ameliorated with the aldose reductase inhibitor.
Ino-ue M; Yokogawa H; Yamamoto M; Naka H; Kuriyama H
Exp Eye Res; 1998 Apr; 66(4):397-401. PubMed ID: 9593633
[TBL] [Abstract][Full Text] [Related]
40. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat.
Reed MJ; Meszaros K; Entes LJ; Claypool MD; Pinkett JG; Gadbois TM; Reaven GM
Metabolism; 2000 Nov; 49(11):1390-4. PubMed ID: 11092499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
